Amphastar Pharmaceuticals, Inc.【AMPH】Cash flow
Market cap
$1.3B
P/E ratio
| 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Stock-based compensation | 8 | 12 | 15 | 17 | 17 | 17 | 20 | 19 | 18 | 20 | 24 |
| Cash from operations | 21 | 11 | 39 | 39 | 38 | 42 | 57 | 98 | 89 | 184 | 213 |
| Capital expenditures | -19 | -14 | -21 | -35 | -47 | -42 | -34 | -27 | -24 | -38 | -41 |
| Cash from investing | -40 | -17 | -40 | -39 | -42 | -51 | -36 | -29 | -33 | -649 | -125 |
| Repurchases of common stock | 0 | 10 | 10 | 31 | 25 | 22 | 24 | 29 | 40 | 58 | 85 |
| Proceeds from issuance of term debt, net | 27 | 7 | 10 | 19 | 8 | 4 | 6 | 70 | - | 845 | - |
| Repayments of term debt | 8 | 9 | 15 | 10 | 6 | 6 | 8 | 37 | 2 | 319 | 8 |
| Cash from financing | 32 | 2 | 7 | -8 | 25 | -4 | -2 | -37 | -26 | 454 | -81 |
| Free cash flow | |||||||||||
| FCF margin (%) |